-
5-fluoro-1-(oxolan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione
-
ChemBase ID:
105021
-
Molecular Formular:
C8H9FN2O3
-
Molecular Mass:
200.1670632
-
Monoisotopic Mass:
200.05972038
-
SMILES and InChIs
SMILES:
Fc1cn(C2CCCO2)c(=O)[nH]c1=O
Canonical SMILES:
O=c1[nH]c(=O)n(cc1F)C1CCCO1
InChI:
InChI=1S/C8H9FN2O3/c9-5-4-11(6-2-1-3-14-6)8(13)10-7(5)12/h4,6H,1-3H2,(H,10,12,13)
InChIKey:
WFWLQNSHRPWKFK-UHFFFAOYSA-N
-
Cite this record
CBID:105021 http://www.chembase.cn/molecule-105021.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
5-fluoro-1-(oxolan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione
|
|
|
IUPAC Traditional name
|
5-fluoro-1-(oxolan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione
|
tegafur
|
|
|
Synonyms
|
5-Fluoro-1-(tetrahydro-2-furyl)uracil
|
Tegafur
|
Furflucil
|
Futraful
|
Neberk
|
Sinoflurol
|
5-FLUORO-1-(TETRAHYDRO-2-FURFURYL)URACIL
|
Ftorafur
|
Tegafur
|
5-Fluoro-1-(tetrahydro-2-furyl)uracil
|
5-fluoro-1-(tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
|
5-Fluoro-1-(tetrahydro-2-furanyl)-2,4(1H,3H)-pyrimidinedione
|
1-(2-Tetrahydrofuryl)-5-fluorouracil
|
5-Fluoro-1-(tetrahydro-2'-furyl)uracil
|
Citofur
|
Coparogin-
|
Exonal
|
FT 207
|
Fental
|
Fluaid
|
Fluorafur
|
Fluorofur
|
Franrose
|
Fulaid
|
Fulfeel
|
Tegafur
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
H Donor
|
1
|
LogD (pH = 5.5)
|
0.020991746
|
LogD (pH = 7.4)
|
-0.1571928
|
Log P
|
0.023826538
|
Molar Refractivity
|
44.5014 cm3
|
Polarizability
|
16.845354 Å3
|
Polar Surface Area
|
58.64 Å2
|
Rotatable Bonds
|
1
|
Lipinski's Rule of Five
|
true
|
Acid pKa
|
7.678831
|
H Acceptors
|
3
|
DETAILS
DETAILS
Sigma Aldrich
TRC
Sigma Aldrich -
T7205
|
Biochem/physiol Actions Tegafur is a pro-drug of 5-fluorouracil, an antimetabolite used as an antineoplastic agent. It has been used as adjuvant chemotherapy for curatively resected colorectal cancer therapy. |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Au., J.L., et al.: Cancer Treat. Rep., 63, 343 (1979)
- • Buroker, T., et al.: Cancer, 44, 48 (1979)
- • Aldrich Library of 13C and 1H FT NMR Spectra, 1992, 3, 366A, (nmr)
- • Aldrich Library of FT-IR Spectra, 1st edn., 1985, 2, 811D, (ir)
- • Yasumoto, M. et al., J. Med. Chem., 1977, 20, 1592, (synth, resoln)
- • Loo, T.L. et al., Drug Metab. Rev., 1978, 8, 137, (metab, rev)
- • Yamamoto, S. et al., Arzneim.-Forsch., 1981, 31, 1268, (pharmacol)
- • Au, J. et al., Cancer Chemother. Pharmacol., 1981, 7, 55, (metab)
- • Nakai, Y. et al., Chem. Pharm. Bull., 1982, 30, 2629; 1986, 34, 1242, (cryst struct, bibl)
- • Fujimoto, S., Drugs of Today (Barcelona), 1985, 21, 125, (rev, pharmacol)
- • Ozaki, S. et al., Chem. Pharm. Bull., 1986, 34, 150, (synth)
- • Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th edn., Akademie-Verlag, 1987, 878
- • Uchida, T. et al., Chem. Pharm. Bull., 1993, 41, 1632, (polymorphism)
- • Martindale, The Extra Pharmacopoeia, 30th edn., Pharmaceutical Press, 1993, 502
- • Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, FMB000; UNJ810
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent